These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8216559)

  • 61. The role of platelet-activating factor (PAF) in interstitial pulmonary disease.
    Martín T; Losa JE; García-Salgado MJ; Pérez-Arellano JL
    J Investig Allergol Clin Immunol; 1994; 4(3):149-57. PubMed ID: 7981886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Renal diseases and platelet activating factor].
    Pirotzky E; Colliez P; Guilmard C; Braquet P
    Pediatrie; 1989; 44(3):163-7. PubMed ID: 2740184
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion.
    Hayashi N; Chihara J; Kobayashi Y; Kakazu T; Kurachi D; Yamamoto T; Nakajima S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):57-9. PubMed ID: 8156006
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis.
    Shult PA; Graziano FM; Busse WW
    J Allergy Clin Immunol; 1986 May; 77(5):702-8. PubMed ID: 3700895
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Eosinophil granulocyte proliferation induced by an intermediate factor generated in the pleural cavity of rats injected with platelet-activating factor-acether.
    Perez SA; Silva PM; Martins MA; el-Cheikh MC; Cordeiro RS; Borojevic R
    Int Arch Allergy Immunol; 1993; 102(4):368-74. PubMed ID: 8241799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells.
    Csato M; Kenderessy AS; Judák R; Dobozy A
    Arch Dermatol Res; 1990; 282(5):348-50. PubMed ID: 2221987
    [No Abstract]   [Full Text] [Related]  

  • 67. Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B cells.
    Patke CL; Green CG; Shearer WT
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):424-32. PubMed ID: 8556480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Priming of circulating human eosinophils following late response to allergen challenge.
    Koenderman L
    Eur Respir J; 1997 Jan; 10(1):251-2. PubMed ID: 9032524
    [No Abstract]   [Full Text] [Related]  

  • 69. Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor.
    Koenderman L; Kuijpers TW; Blom M; Tool AT; Roos D; Verhoeven AJ
    J Allergy Clin Immunol; 1991 May; 87(5):947-54. PubMed ID: 1673978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan.
    Parnham MJ; Bittner C
    Int J Immunopharmacol; 1986; 8(8):951-9. PubMed ID: 3804536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro.
    Matsumoto K; Schleimer RP; Saito H; Iikura Y; Bochner BS
    Blood; 1995 Aug; 86(4):1437-43. PubMed ID: 7543306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence.
    Romaschin AD; Harris DM; Ribeiro MB; Paice J; Foster DM; Walker PM; Marshall JC
    J Immunol Methods; 1998 Mar; 212(2):169-85. PubMed ID: 9672205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.
    McKinnon M; Page K; Uings IJ; Banks M; Fattah D; Proudfoot AE; Graber P; Arod C; Fish R; Wells TN; Solari R
    J Exp Med; 1997 Jul; 186(1):121-9. PubMed ID: 9207003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects.
    Mahmoud FF; Abul HT; Haines DD; Abal AT; Wise JA
    Transplant Proc; 2002 Nov; 34(7):2958-61. PubMed ID: 12431672
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects.
    Roberts NM; Page CP; Chung KF; Barnes PJ
    J Allergy Clin Immunol; 1988 Aug; 82(2):236-41. PubMed ID: 3403863
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Theophylline at therapeutic concentration suppresses PAF-induced upregulation of Mac-1 on human eosinophils.
    Sagara H; Fukuda T; Okada T; Ishikawa A; Makino S
    Clin Exp Allergy; 1996 Mar; 26 Suppl 2():16-21. PubMed ID: 8963871
    [No Abstract]   [Full Text] [Related]  

  • 77. Cytokine trafficking of IL-9 and IL-13 through TfnRc
    Almas S; Fayad N; Srivastava O; Siddique M; Touret N; Lacy P
    J Leukoc Biol; 2021 Apr; 109(4):753-762. PubMed ID: 32911568
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of Lidocaine-Derived Organic Compounds on Eosinophil Activation and Survival.
    Shin SH; Ye MK; Chae MH; Geum SY; Aboraia AS; Abdel-Aal AM; Qayed WS; Abd El-Wahab HAA; Abou-Ghadir OF; Aboul-Fadl T
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570665
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.
    Henocq E; Vargaftig BB
    Lancet; 1986 Jun; 1(8494):1378-9. PubMed ID: 2872485
    [No Abstract]   [Full Text] [Related]  

  • 80. Dual Transmembrane Signalling Mechanisms in Eosinophils: Evidence for Two Functionally Distinct Receptors for Platelet-Activating Factor.
    Kroegel C; Warner JA; Giembycz MA; Matthys H; Lichtenstein LM; Barnes PJ
    Int Arch Allergy Immunol; 1992; 99(2-4):226-229. PubMed ID: 34167200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.